Regencell Bioscience (RGC) | Stock Overview & Key Data

Regencell Bioscience Holdings Ltd. | Large-cap | Healthcare

$17.04

-2.07%

| Regencell Bioscience Stock Comparison:

Regencell Bioscience vs Zoetis Regencell Bioscience vs Haleon Plc - ADR Regencell Bioscience vs Elanco Animal Health Regencell Bioscience vs Lantheus Holdings Regencell Bioscience vs Alkermes plc Regencell Bioscience vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Regencell Bioscience Performance Comparison

Loading chart data...

Regencell Bioscience

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $15.11 High: $17.85

on June 30, 2025

52 Week Range

Low: $0.08 High: $83.60

on June 16, 2025

All-Time High: $950.00 on May 30, 2025

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $18.5B

EPS i -0.01

P/E Ratio (TTM) i N/A

Forward P/E i N/A

P/B Ratio i 1,394.12

PEG Ratio i N/A

Div. Yield i N/A

ROE i -43.18%

Beta i 2.618

Debt to Equity i 1.04

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 0.00%

Profit Margin i 0.00%

Returns and Earnings

Return on Assets (TTM) i -28.11%

Return on Equity (TTM) i -43.18%

EBITDA i $-4.4M

Net Income (TTM) i $-4.3M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i N/A

Quarterly Earnings Growth i N/A

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Regencell Bioscience RGC	18.54B Large-cap	-28.10%	-98.06%	-46.55%	253.53%	253.53%	369.42%	-55.16%	62.29%
Zoetis ZTS	70.27B Large-cap	-0.88%	-7.52%	-5.28%	-3.88%	-4.10%	-10.13%	-10.57%	13.17%
Haleon Plc - ADR HLN	47.20B Large-cap	-1.14%	-8.63%	0.78%	9.04%	9.85%	22.43%	39.95%	39.95%
Elanco Animal Health ELAN	6.63B Mid-cap	6.97%	6.25%	36.00%	20.81%	18.51%	0.42%	-30.17%	-35.18%
Lantheus Holdings LNTH	5.60B Mid-cap	1.30%	8.34%	-16.13%	-8.16%	-7.82%	3.76%	20.76%	467.68%
Alkermes plc ALKS	4.83B Mid-cap	-2.22%	-6.53%	-13.36%	-0.59%	-0.49%	17.79%	-10.17%	45.30%

Ownership & Short Interest

Insider Ownership i 93.84%

Institutional Ownership i 0.07%

Shares Short i 760K

Short Ratio i 0.16

Short % of Shares Outstanding i 31.31%

Average 10-Day Volume i 2M

Average 90-Day Volume i 2M

Regencell Bioscience Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Regencell Bioscience would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is RGC's 52-week high and low?

In the last 52 weeks, Regencell Bioscience reached a high of $83.60 (on June 16, 2025) and a low of $0.08 (on N/A).

What is the market cap and P/E ratio for RGC?

Curious about Regencell Bioscience's size and valuation? Its market capitalization stands at 18.54B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.

Does RGC pay dividends? If so, what's the yield?

As for dividends, Regencell Bioscience isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Regencell Bioscience's main competitors or similar companies to consider before investing?

When looking at Regencell Bioscience, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Zoetis ZTS	70.27B	Healthcare	Drug Manufacturers - Specialty & Generic	-10.13%	-10.57%
Haleon Plc - ADR HLN	47.20B	Healthcare	Drug Manufacturers - Specialty & Generic	22.43%	39.95%
Elanco Animal Health ELAN	6.63B	Healthcare	Drug Manufacturers - Specialty & Generic	0.42%	-30.17%
Lantheus Holdings LNTH	5.60B	Healthcare	Drug Manufacturers - Specialty & Generic	3.76%	20.76%
Alkermes plc ALKS	4.83B	Healthcare	Drug Manufacturers - Specialty & Generic	17.79%	-10.17%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Regencell Bioscience Holdings Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Regencell Bioscience's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -43.18%, the Debt to Equity ratio from the most recent quarter is 1.04, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for RGC?

Looking at Regencell Bioscience's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of RGC stock is held by insiders and institutions?

Wondering who owns Regencell Bioscience stock? Company insiders (like executives and directors) hold about 93.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.07%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.